SCHEMBL12698692

SCHEMBL12698692

C[C@@H]1CN(C(=O)c2ccc(N)cc2)CCN1C(=O)c1ccccn1

nearest known ligand 0.52

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 3/20 0.52
▸ SLC6A7 Q99884 3/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ HTT P42858 1/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ CYP2D6 P10635 2/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ SMO Q99835 5/20 0.45
▸ PLA2G1B P04054 1/20 0.44
▸ ATG4B Q9Y4P1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12698697 1.00 GHSR (0.52) GHSRSLC6A7SMN1; SMN2L3MBTL1HTT
SCHEMBL13825034 0.95 SMN1; SMN2 (0.53) GHSRSLC6A7SMN1; SMN2L3MBTL1HTT
SCHEMBL12698700 0.95 SMN1; SMN2 (0.53) GHSRSLC6A7SMN1; SMN2L3MBTL1HTT
SCHEMBL12761089 0.83 L3MBTL1 (0.57) GHSRSLC6A7SMN1; SMN2L3MBTL1HTT
SCHEMBL20192340 0.83 L3MBTL1 (0.73) SLC6A7SMN1; SMN2L3MBTL1HTT
SCHEMBL26814604 0.80 L3MBTL1 (0.54) GHSRSLC6A7SMN1; SMN2L3MBTL1HTT
SCHEMBL1946155 0.77 SETD7 (0.52) SMN1; SMN2L3MBTL1
SCHEMBL20750605 0.76 L3MBTL1 (0.51) GHSRL3MBTL1HTT
SCHEMBL10261766 0.76 PKLR (0.62) —
SCHEMBL10267625 0.76 PKLR (0.62) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012151452-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY AGIOS PHARMACEUTICALS, INC (US) 2012-11-08 — — WO disclosed
WO-2012092442-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS AGIOS PHARMACEUTICALS, INC. (US) 2012-07-05 — — WO disclosed
Send feedback